Clinical evaluation of biosynthetic glucagon treatment for recovery from hypoglycemia developed in diabetic patients
- 1 February 1993
- journal article
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 19 (2) , 133-138
- https://doi.org/10.1016/0168-8227(93)90106-f
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Study on Recombinant Hepatitis B Vaccine : Development of ELISA Methods for Detection of Contaminating Yeast Components in the Vaccine and Humoral Anti-yeast Component Antibody Developed in Humans and Guinea-pigsYAKUGAKU ZASSHI, 1988
- The secretion of glucagon by transformed yeast strainsFEBS Letters, 1987
- Cross-reacting human and rabbit antibodies to antigens of Histoplasma capsulatum, Candida albicans, and Saccharomyces cerevisiaeInfection and Immunity, 1985
- Pharmacokinetics and Bioavailability of Injected Glucagon: Differences Between Intramuscular, Subcutaneous, and Intravenous AdministrationDiabetes Care, 1985
- Clinical evaluation in healthy adults of a hepatitis B vaccine made by recombinant DNAPublished by American Medical Association (AMA) ,1984
- The Amino Acid Sequence of GlucagonDiabetes, 1957